ACADEMIA
INDUSTRY
IDEAS
IMPACT
DISCOVERY
PARTNERSHIPS
COLLABORATION
COMMERCIALISATION
RESEARCH
TRANSLATION
MONASH UNIVERSITY
THE UNIVERSITY OF MELBOURNE

ACADEMIA
INDUSTRY
IDEAS
IMPACT
DISCOVERY
PARTNERSHIPS
COLLABORATION
COMMERCIALISATION
RESEARCH
TRANSLATION
MONASH UNIVERSITY
THE UNIVERSITY OF MELBOURNE

Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

Twitter feed

#COVID19 has seen medical research slow or completely halt. While we support Aus #COVID19 efforts, BioCurate are still full speed ahead progressing drug development to address critical unmet needs like epilepsy & cancer https://wapo.st/3dBStSu

Monash Uni has formed a research partnership with @oNKo_innate. This new model of partnership highlights @MonashBDI's vision of fostering an innovation-led environment where researchers are encouraged to partner with industry and establish their own start-ups. @Monash_FMNHS

BioCurate is a proud supporter of the Melbourne entrepreneurial community & we're excited for this year's @MAPUniMelb Launch. The virtual launch will introduce the 2020 MAP cohort & see these teams present their successful pitches. More info https://bit.ly/306YrXW

Dr Kate Murphy, NHMRC Career Development Fellow, the University of Melbourne

“Our interactions with BioCurate have changed the way that we view our research and is being used to inform the development and direction of current and future projects for greater impact and commercial potential.”

“BioCurate brings deep industry perspective to select opportunities most likely to appeal to biotechnology and pharmaceutical companies, to confirm or extend the properties essential to entice those partners, and to communicate the science in a way that enables ready assessment of fit. This is hugely valuable to industry licensing efforts and will increase the probability of commercialization of the academic work.

I expect BioCurate to be on the top of the list of places where industry will hunt for early drug candidates.”

Penelope Lane, Senior Business Development Manager, the University of Melbourne

“Working with the team at BioCurate towards translation and commercialisation of medical research from the University of Melbourne has been a comprehensive, professional and considered experience, allowing the researchers, commercialisation teams and funds to successfully navigate investment into early stage medical research.

Collaboration of this nature is a best practice example in support of a truly innovative ecosystem for medical research.”

“There is in most research environments a substantial gap in understanding as to what it takes to move from discovery to commercialisation, or even investment….and I strongly believe the single biggest impact at this stage is the experience our researchers have had discussing the process and expectations with your team….

Congratulations on everything you and your team have achieved in such a short time and in what is a completely new landscape.”

“There is in most research environments a substantial gap in understanding as to what it takes to move from discovery to commercialisation, or even investment….and I strongly believe the single biggest impact at this stage is the experience our researchers have had discussing the process and expectations with your team….

Congratulations on everything you and your team have achieved in such a short time and in what is a completely new landscape.”

“BioCurate brings deep industry perspective to select opportunities most likely to appeal to biotechnology and pharmaceutical companies, to confirm or extend the properties essential to entice those partners, and to communicate the science in a way that enables ready assessment of fit. This is hugely valuable to industry licensing efforts and will increase the probability of commercialization of the academic work.

I expect BioCurate to be on the top of the list of places where industry will hunt for early drug candidates.”

Penelope Lane, Senior Business Development Manager, the University of Melbourne

“Working with the team at BioCurate towards translation and commercialisation of medical research from the University of Melbourne has been a comprehensive, professional and considered experience, allowing the researchers, commercialisation teams and funds to successfully navigate investment into early stage medical research.

Collaboration of this nature is a best practice example in support of a truly innovative ecosystem for medical research.”